Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups

  • staffstaff
  • AI
  • January 28, 2025
  • 0 Comments

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an AI-powered drug discovery startup, Manas AI. The company, which will initially focus on breast cancer, prostate cancer, and lymphoma, has raised $24.6 million in seed funding from Hoffman, General Catalyst, and Greylock. Manas […]

© 2024 TechCrunch. All rights reserved. For personal use only.

  • Related Posts

    Lawyers could face ‘severe’ penalties for fake AI-generated citations, UK court warns

    he High Court of England and Wales says lawyers need to take stronger steps to prevent the misuse of artificial intelligence in their work. In a ruling tying together two…

    Continue reading
    Trump administration takes aim at Biden and Obama cybersecurity rules

    In a White House fact sheet, the administration claims that Biden’s Executive Order 14144 — signed days before the end of his presidency — was an attempt “to sneak problematic…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Lawyers could face ‘severe’ penalties for fake AI-generated citations, UK court warns

    • By staff
    • June 7, 2025
    • 1 views

    Trump administration takes aim at Biden and Obama cybersecurity rules

    • By staff
    • June 7, 2025
    • 1 views

    Will Musk vs. Trump affect xAI’s $5 billion debt deal?

    • By staff
    • June 7, 2025
    • 1 views

    Week in Review: Why Anthropic cut access to Windsurf

    • By staff
    • June 7, 2025
    • 1 views

    Building More Scalable GenAI Applications for Startups and Developers

    • By staff
    • June 7, 2025
    • 1 views

    Building Your AI Engine: How OpenAI Works with Startups

    • By staff
    • June 7, 2025
    • 1 views